Paul Grayson
Chairman
Skye Bioscience, Inc. (SKYE)Board Member
Skye Bioscience, Inc. (SKYE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Paul Grayson
Paul Grayson is recorded as Chairman and Board Member at Skye Bioscience, Inc. (SKYE). Skye Bioscience, Inc. reported in an 8-K filed October 29, 2024 that Paul Grayson was appointed Chairman of the Board, effective October 25, 2024. Skye Bioscience, Inc. reported in an 8-K filed August 21, 2023 that Paul Grayson was appointed Venture Partner, Versant & CEO, Tentarix. Skye Bioscience, Inc. reported in an 8-K filed August 21, 2023 that Paul Grayson was appointed Board, effective August 18, 2023.
“the Board has appointed independent director Paul Grayson as Skye's new Chairman of the Board, effective October 25, 2024.”
“Existing board of directors expanded with addition of Andy Schwab (Managing Partner, 5AM Ventures) and Paul Grayson (Venture Partner, Versant & CEO, Tentarix)”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-10-25–present
-
Current
2023-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Skye Bioscience, Inc.
Other people whose current roles at this company are on record from its filings.
- Lisa Anson CEO
- Punit Dhillon CEO, Chief Accounting Officer, Board Member
- Elena Traistaru CFO
- Kaitlyn Arsenault CFO
- Peter Collum CFO
- Tu Diep COO
- Dr. Cliff Jones CTO
- Richard Janney Chief Accounting Officer
- Andrew J. Schwab Board Member
- Andrew Schwab Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.